Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. (Q40124037)
Jump to navigation
Jump to search
scientific article published on June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. |
scientific article published on June 2007 |
Statements
1 reference
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. (English)
1 reference
Teruo Kaiga
1 reference
Marimo Sato
1 reference
Hide Kaneda
1 reference
Yoichiro Iwakura
1 reference
Tadatoshi Takayama
1 reference
Hideaki Tahara
1 reference
1 June 2007
1 reference
1 reference
7571-7580
1 reference
Identifiers
1 reference